Back to search

Article

ADAMTS3 as a promising novel biomarker for the diagnosis of hepatocellular carcinoma

2025-09-20

Abstract excerpt

Early diagnosis of hepatocellular carcinoma (HCC) still represents a significant challenge. The rising of obesity and non-viral liver disease associated HCC further limits the effectiveness of conventional screening approaches such as ultrasonography and alpha-fetoprotein (AFP) testing. In this context, the identification of potential effective biomarkers for rapid and precise diagnosis of HCC still represents an...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d22cda38-d7ba-5918-acf9-e520f852330b
DOI
10.1101/2025.09.17.676767
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
ADAMTS3 as a promising novel biomarker for the diagnosis of hepatocellular carcinomaDOI 10.1101/2025.09.17.676767
Unraveling the role of ADAMs in clinical heterogeneity and the immune microenvironment of hepatocellular carcinoma: insights from single-cell, spatial transcriptomics, and bulk RNA sequencingSemantic proximity
Screening of Hepatocellular Carcinoma in Hepatic Cirrhosis Patients by a Novel Blood-Based Multi-Omics Test.Semantic proximity
Serine Protease Inhibitor Kazal Type 1, A Potential Biomarker for the Early Detection, Targeting, and Prediction of Response to Immune Checkpoint Blockade Therapies in Hepatocellular CarcinomaSemantic proximity
A pan-cancer study of ADAM9’s immunological function and prognostic value particularly in liver cancerSemantic proximity
Serum Proteins, HMMR, NXPH4, PITX1 and THBS4; A Panel of Biomarkers for Early Diagnosis of Hepatocellular CarcinomaSemantic proximity
Targeting MMP9 in CTNNB1 mutant hepatocellular carcinoma restores CD8+ T cell-mediated antitumour immunity and improves anti-PD-1 efficacy.Semantic proximity
Targeting hepatocellular carcinoma with aptamers: from biomarker detection to therapeutic applicationsSemantic proximity
Alpha-fetoprotein: Past, present, and futureSemantic proximity
SEPT9 Gene Methylation as a Noninvasive Marker for Hepatocellular CarcinomaSemantic proximity
Plasma mSEPT9: A Novel Circulating Cell-free DNA-Based Epigenetic Biomarker to Diagnose Hepatocellular CarcinomaSemantic proximity
The Fontan EV Score: A Circulating Extracellular Vesicle-Based Risk Stratification Tool for Fontan-Associated Liver DiseaseSemantic proximity
Selection of a Clinical Lead TCR Targeting Alpha-Fetoprotein-Positive Liver Cancer Based on a Balance of Risk and BenefitSemantic proximity
Select a neighboring publication to make it the new centre.